Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Velaresol is an oxyhemoglobin (Hb-O2) stabilizer.1 It increases erythrocyte deformability in isolated human blood from a patient with sickle cell disease when used at a concentration of 1.5 mM. Velaresol (3 or 5 mM) inhibits deoxygenation-induced decreases in erythrocyte deformability in isolated human blood from a patient with sickle cell disease. It decreases oxygen tension and increases oxygen saturation of isolated human sickle erythrocytes when used at a concentration of 5 mM.2
WARNING This product is not for human or veterinary use.
1. Preservation of deformability (filterability) of sickle cells by BW12C during progressive deoxygenation. Br. J. Haematol. 55(3), 465-471 (1983).
2. O2 dependence of K+ transport in sickle cells: The effect of different cell populations and the substituted benzaldehyde 12C79. The FASEB Journal 15(3), 823-832 (2001).